Other lipid-modifying drugs by all CCGs

Why it matters: NICE guidance suggests that, for the vast majority of people who need treatment for high cholesterol, these drugs should not be used. There is no evidence that omega 3 fatty acids reduce the chances of patients getting cardiovascular disease.

Description: Total cost of prescriptions for bile acid sequestrants, fibrates, nicotinic acid, and omega-3 fatty acid compounds per 1000 registered patients

Performance: Loading...


Tagged as: Cardiovascular system, Standard, Efficacy, NICE (or browse all measures)

CCGs are ordered by mean percentile over the past six months. Each chart shows the results for the individual CCG, plus deciles across all CCGs in the NHS in England.

View measure for NHS England combined →

Fetching data...

Do you need help with your analysis? Don't forget to check the FAQ page, and if you have questions.